<p>We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.</p>

We discuss the first interim results of a novel intravitreal gene therapy agent, 4D-150, with Dr. Arshad Khanani of Sierra Eye Associates and the University of Nevada Reno School of Medicine.

Intravitreal Gene Therapy for neovascular AMD with 4D-150

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

Share Intravitreal Gene Therapy for neovascular AMD with 4D-150

Sign up to save your podcasts

Intravitreal Gene Therapy for neovascular AMD with 4D-150

Intravitreal Gene Therapy for neovascular AMD with 4D-150

More shows like Retina Synthesis

Straight From The Cutter's Mouth: A Retina Podcast